These are all Buys if you can manage the risk.
Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. These reports cover stocks to buy
Below is our list for Tuesday, 26 May, as follows:
Aquestive Therapeutics Inc. (NASDAQ:AQST) was reiterated as Buy and its price target was raised to 15 from 13 at HC Wainwright. Friday, shares were indicated up almost 9% at 6.70 after a royalty program it was involved in with Sunovion Pharmaceuticals received FDA approval.
Chegg Inc. (NYSE:CHGG) online education tools likely will be vital for students and teachers going forward. Shares most recently closed at 64.91, with a consensus price target of 44.50.
Marvell Technology Group Ltd. (NASDAQ:MRVL) was reiterated as Buy and its price target was raised to 34 from 31 at B. Riley FBR. It had a 28.83 consensus price target.
Splunk Inc. (NASDAQ:SPLK) was reiterated as Buy and its price target was raised to 190 from 160 at Stifel. Shares were indicated up over 6% at 174.00 Friday. Needham reiterated it as Buy and raised its price target to 192 from 168.
Have a healthy week, Keep the Faith!
Paul Ebeling
Latest posts by Paul Ebeling (see all)
- Catching COVID-19 Outdoors is Next to Impossible - January 22, 2021
- US Stocks Driving Due North, as Professional Investors Hedge Bets - January 22, 2021
- This Administration’s $1.9-T Aid/Relief/Stimulus Bill Facing Headwinds in Senate - January 22, 2021